“Real time” is frequently cited in the life sciences industry, yet rarely defined in operational terms. This article clarifies what real-time operations truly mean in GMP-regulated environments, contrasts batch-based execution with continuous decision-making, and explains why reducing decision latency is critical for quality, reliability, and performance. It also outlines the governance, evidence, and operating model patterns that make real-time execution compliant and scalable, and shows how Haptiq enables this shift with observability, governed context, and outcome linkage.